VIR BIOTECHNOLOGY INC (VIR) Earnings History & Surprises

NASDAQ:VIR • US92764N1028

9.82 USD
-0.06 (-0.61%)
At close: Mar 11, 2026
9.82 USD
0 (0%)
After Hours: 3/11/2026, 4:10:11 PM

Past quarterly earnings results for VIR BIOTECHNOLOGY INC (VIR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateMay 5, 2026
PeriodQ1 / 2026
EPS Estimate-$0.40
Revenue Estimate2.101M

Last Reported

Most Recent
Release DateFeb 23, 2026
PeriodQ4 / 2025
EPS Reported-$0.31
EPS Surprise 37.56%
Revenue Surprise 173.63%

Beat Rate

Last 8 Quarters
38%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.31 -0.50 37.56% 59.21% 64.07M 23.415M 173.63% 417.78%
Q3 2025 -1.17 -0.86 -35.70% 25.00% 240K 2.003M -88.02% -89.92%
Q2 2025 -0.80 -0.73 -9.48% 21.57% 1.214M 2.749M -55.84% -60.52%
Q1 2025 -0.88 -0.84 -4.26% -83.33% 3.032M 8.678M -65.06% -94.62%
Q4 2024 -0.76 -0.88 13.76% 11.63% 12.374M 8.221M 50.52% -26.29%
Q3 2024 -1.56 -1.06 -46.72% -27.87% 2.38M 5.565M -57.23% -9.81%
Q2 2024 -1.02 -0.90 -12.81% 29.66% 3.075M 7.571M -59.38% -19.02%
Q1 2024 -0.48 -1.06 54.80% 54.72% 56.376M 11.829M 376.59% -10.45%
Q4 2023 -0.86 -1.02 15.51% -13.16% 16.787M 12.276M 36.75% -66.02%
Q3 2023 -1.22 -1.22 -0.20% -193.85% 2.639M 10.339M -74.48% -99.30%
Q2 2023 -1.45 -1.22 -19.31% -150.00% 3.797M 26.145M -85.48% 109.35%
Q1 2023 -1.06 -0.88 -20.02% -127.53% 62.957M 50.6M 24.42% -94.89%
Q4 2022 -0.76 -0.40 -90.50% -119.39% 49.4M 98.278M -49.73% -93.92%
Q3 2022 1.30 -0.22 704.29% 58.54% 374.6M 173.16M 116.33% 261.58%
Q2 2022 -0.58 0.11 -648.22% -226.09% -40.6M 217.53M -118.66% -122.92%
Q1 2022 3.85 3.82 0.84% 391.67% 1.233B 845.34M 45.80% 61,525.00%
Q4 2021 3.92 3.07 27.67% 572.29% 812.7M 629.13M 29.18% 47,705.88%
Q3 2021 0.82 0.02 3,451.54% 222.39% 103.6M 139.63M -25.80% 5,352.63%
Q2 2021 0.46 -0.48 195.45% 270.37% 177.1M 85.409M 107.36% 164.33%
Q1 2021 -1.32 -0.21 -513.99% -85.92% 2M 99.62M -97.99% -64.91%
Q4 2020 -0.83 -0.71 -16.97% - 1.7M 4.863M -65.04% -
Q3 2020 -0.67 -0.60 -11.05% - 1.9M 19.195M -90.10% -
Q2 2020 -0.27 -0.62 56.66% - 67M 3.935M 1,602.67% -
Q1 2020 -0.71 -0.53 -33.19% - 5.7M 2.946M 93.48% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

VIR EPS Q2Q GrowthVIR EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 200 -200 400

Revenue Historical Q2Q growth and Acceleration

VIR Revenue Q2Q GrowthVIR Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 20K 40K 60K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
1
Average EPS beat (4)
-2.97%
Max EPS beat (4)
37.56%
Min EPS beat (4)
-35.70%

Revenue beat statistics

Revenue beat (4)
1
Average Revenue beat (4)
-8.82%
Max Revenue beat (4)
173.63%
Min Revenue beat (4)
-88.02%

Analysis

In the last 4 quarters, VIR has beaten EPS estimates in 1 out of 4 releases
VIR has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, VIR reported -3.0% below the EPS estimates on average.
In the last 4 quarters, VIR reported -8.8% below the revenue estimates on average.
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

VIR BIOTECHNOLOGY INC / VIR Earnings FAQ

What is the most recent earnings date for VIR stock?

VIR BIOTECHNOLOGY INC (VIR) last reported earnings on 2/23/2026.


Did VIR BIOTECHNOLOGY INC (VIR) beat earnings estimates last quarter?

VIR BIOTECHNOLOGY INC (VIR) beat EPS estimates and beat revenue estimates in the most recent quarter.


Can you provide information on how often VIR BIOTECHNOLOGY INC beats earnings estimates?

In the last 4 quarters, VIR BIOTECHNOLOGY INC (VIR) has beaten EPS estimates in 1 out of 4 releases.